Huashi baidu granule in the treatment of pediatric patients with mild coronavirus disease 2019: A single-center, open-label, parallel-group randomized controlled clinical trial

Background: Since late February 2022, a wave of coronavirus disease 2019 (COVID-19) mainly caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant rapidly appeared in Shanghai, China. Traditional Chinese medicine treatment is recommended for pediatric patients; how...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jiande, Tang, Qiuyu, Zhang, Baoqin, Yuan, Shuhua, Chen, Jia, Shen, Shiyu, Wang, Dong, Lin, Jilei, Dong, Hongliang, Yin, Yong, Gao, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892187/
https://www.ncbi.nlm.nih.gov/pubmed/36744267
http://dx.doi.org/10.3389/fphar.2023.1092748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892187/
https://www.ncbi.nlm.nih.gov/pubmed/36744267
http://dx.doi.org/10.3389/fphar.2023.1092748

Ejemplares similares